SCHEMBL6501955

SCHEMBL6501955

COc1c(N2CCC(C(O)O)C2)c(F)cc2c(=O)n(N)c(=O)n(C3CC3)c12

nearest known ligand 0.83

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.51
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PRKD3 O94806 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
OPRM1 P35372 1/20 0.41
CLK2 P49760 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CACNA1C Q13936 1/20 0.41
SCN5A Q14524 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6376661 0.94 KCNH2 (0.47) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL5463875 0.92 KCNH2 (0.49) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL6491029 0.91 KCNH2 (0.49) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL14432209 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5458141 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4715900 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4509664 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4509668 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4513354 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4513351 0.91 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119231-A1 Quinolone antibacterial agents ELLSWORTH EDMUND L (US) 2005-06-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119231-A1 Quinolone antibacterial agents NQO2, MRPL21, TOP1 KCNH2 2108/4885POLB 303/4885KDM4E 4453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.